CCEP Congressional Stock Trades
COCA-COLA EUROPEAN PARTNERS PL CMN
Last disclosed trade Jun 5
Every disclosed trade in CCEP by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.
Sample · the intelligence layer
Rohit Khanna · Sold $CCEP · Jun 5 · $1K–$15K
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow $CCEP
Get notified when any member of Congress trades $CCEP. Free, no card, no spam.
The record on $CCEP
Coldpine has parsed 7 disclosed trades in $CCEP by 2 members of Congress, drawn from 7 periodic transaction reports dated Feb 14, 2023 through Jun 5, 2026. That is 6 trades from House members and 1 trade from senators, filed 6 by Democrats and 1 by Republicans.
Of the 7 trades with a known filing lag, 1 was reported more than 45 days after the trade date, outside the window the STOCK Act sets. The median lag was 31 days. The longest was 113 days: a $CCEP purchase by Alan Armstrong dated Mar 30, 2026, disclosed Jul 21, 2026. How late filing is measured across all of Congress is in the late-filers study.
6 of the 7 trades that list an account holder (86%) were reported under a spouse, dependent child, or joint account rather than the member directly.
Alan Armstrong filed the most $CCEP purchases (1), and Rohit Khanna the most sales (6).
Activity peaked in 2025 with 3 trades.
Members who trade CCEP
Recent disclosed trades in CCEP
| Date | Member | Type | Amount |
|---|---|---|---|
| Jun 5 | Rohit Khanna(CA) | sell | $1K–$15K |
| Mar 30 | Alan Armstrong(OK) | buy | $1K–$15K |
| Nov 7 | Rohit Khanna(CA) | sell | $1K–$15K |
| Sep 5 | Rohit Khanna(CA) | sell | $1K–$15K |
| Jul 2 | Rohit Khanna(CA) | sell | — |
| Feb 9 | Rohit Khanna(CA) | sell | $1K–$15K |
| Feb 14 | Rohit Khanna(CA) | sell | $1K–$15K |
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →